학술논문
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial
Document Type
Article
Author
Jackson, Daniel J ; Bacharier, Leonard B; Gergen, Peter J; Gagalis, Lisa; Calatroni, Agustin; Wellford, Stephanie; Gill, Michelle A; Stokes, Jeffrey; Liu, Andrew H; Gruchalla, Rebecca S; Cohen, Robyn T; Makhija, Melanie; Khurana Hershey, Gurjit K; O'Connor, George T; Pongracic, Jacqueline A; Sherenian, Michael G; Rivera-Spoljaric, Katherine; Zoratti, Edward M; Teach, Stephen J; Kattan, Meyer; Dutmer, Cullen M; Kim, Haejin; Lamm, Carin; Sheehan, William J; Segnitz, R Max; Dill-McFarland, Kimberly A; Visness, Cynthia M; Becker, Patrice M; Gern, James E; Sorkness, Christine A; Busse, William W; Altman, Matthew C
Source
In The Lancet 13-19 August 2022 400(10351):502-511
Subject
Language
ISSN
0140-6736